Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

GPACGeneral Purpose Acquisition Corp.

Nasdaq · CIK 0002085408
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6770 Blank Checks
FY end1231
XBRL facts55

Identity from submissions API

NameGeneral Purpose Acquisition Corp.
CIK0002085408
TickersGPAC, GPACU, GPACW
ExchangesNasdaq, Nasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6770 Blank Checks
EIN000000000
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone845-677-4650
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
59 FRONT STREET
MILLBROOK
NY
12545
NY
Mailing address
59 FRONT STREET
MILLBROOK
NY
12545
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

33 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001076809-26-000196 005-95372 261565795 34 10795
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001076809-26-000142 005-95372 261560910 34 10006
2026-11-09 10-Q 10-Q 0001140361-26-042717 001-42986 261535014 34 4429003 1 1
2026-08-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001076809-26-000083 005-95372 261274959 34 9302
2026-08-06 10-Q 10-Q 0001140361-26-031673 001-42986 261248937 34 4052363 1 1
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-224019 005-95372 26978940 34 8377
2026-05-12 10-Q 10-Q 0001140361-26-020807 001-42986 26968494 34 3763639 1 1
2026-04-23 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-047685 005-95372 26888617 34 15522
2026-03-27 10-K 10-K 0001140361-26-011732 001-42986 26807324 34 5638943 1 1
2026-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-051268 005-95372 26632281 34 8081
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000887 005-95372 26623650 34 16137
2026-01-22 8-K 8-K 8.01,9.01 0001140361-26-002064 001-42986 26552379 34 229431 1 1
2025-12-10 8-K 8-K 8.01,9.01 0001140361-25-045151 001-42986 251562595 34 405086 1 1
2025-12-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-119316 005-95372 251556407 34 15166
2025-12-04 4 FORM 4 0001140361-25-044372 5491
2025-12-04 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001140361-25-044365 005-95372 251550346 34 39121
2025-12-04 8-K 8-K 1.01,3.02,5.02,5.03,8.01,9.01 0001140361-25-044361 001-42986 251550186 34 1652507 1 1
2025-12-03 424B4 424B4 0001140361-25-044114 333-290856 251545077 33 2538684
2025-12-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003471 333-290856 251544898 33 1720
2025-12-02 3 FORM 3 0001140361-25-044063 18833
2025-12-02 3 FORM 3 0001140361-25-044062 14155
2025-12-02 3 FORM 3 0001140361-25-044061 13008
2025-12-02 3 FORM 3 0001140361-25-044060 12870
2025-12-02 3 FORM 3 0001140361-25-044059 13294
2025-12-02 3 FORM 3 0001140361-25-044058 12926
2025-12-02 3 FORM 3 0001140361-25-044057 12857
2025-12-02 3 FORM 3 0001140361-25-044056 13722
2025-12-02 CERT 8A_CERT_GPAC_0002085408.pdf 0001354457-25-001199 001-42986 251542761 34 123755
2025-12-02 8-A12B 8-A12B 0001140361-25-043933 001-42986 251542264 34 15989
2025-11-18 S-1/A S-1/A 0001140361-25-042608 333-290856 251495400 33 5486186 1 1
2025-10-31 S-1/A S-1/A 0001140361-25-040015 333-290856 251440846 33 116882
2025-10-14 S-1 S-1 0001140361-25-038051 333-290856 251390420 33 8351166 1 1
2025-09-10 DRS filename1.htm 0001140361-25-034565 377-08439 251305971 33 2587730

Latest XBRL company facts

One latest value per concept from companyfacts (55 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-03-27 0001140361-26-011732
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1,250 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 266,746 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 243,321 2025-07-25 2025-12-31 2025 FY 10-K 2026-03-27 0001140361-26-011732
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 3.91M 2025-07-25 2025-12-31 2025 FY 10-K 2026-03-27 0001140361-26-011732
us-gaap Assets Assets USD 237.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap AssetsCurrent Assets, Current USD 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 236.75M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap AssetsNoncurrent Assets, Noncurrent USD 236.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap Cash Cash USD 878,221 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 878,221 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -285,393 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 11.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 14.30M 2025-12-04 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 681,386 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -29,903 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 110,526 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 225,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -92,463 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 6.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap Liabilities Liabilities USD 9.72M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 237.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap LiabilitiesCurrent Liabilities, Current USD 515,577 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 9.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -2,093 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -230.00M 2025-07-25 2025-12-31 2025 FY 10-K 2026-03-27 0001140361-26-011732
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -283,300 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 5.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -681,386 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 247,581 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 6.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2,093 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 230.00M 2025-07-25 2025-12-31 2025 FY 10-K 2026-03-27 0001140361-26-011732
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 123,285 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 20,880 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 230.00M 2025-12-04 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 6.60M 2025-12-04 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 300,000 2025-07-25 2025-12-31 2025 FY 10-K 2026-03-27 0001140361-26-011732
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 300,000 2025-07-25 2025-12-31 2025 FY 10-K 2026-03-27 0001140361-26-011732
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -8.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 10 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -8.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 25,000 2025-07-25 2025-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 6.60M 2025-07-25 2025-12-31 2025 FY 10-K 2026-03-27 0001140361-26-011732
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 2.22M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001140361-26-042717

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →